Sleep, cognition & neuro
Dihexa
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
An angiotensin IV analog studied for synapse formation via hepatocyte growth factor signaling.
What it is
Dihexa is a small molecule derived from angiotensin IV, studied for potent effects on HGF/c-Met signaling and synaptogenesis in animal models of cognitive impairment. Its reported potency is exactly why caution is warranted.
What it's studied for
- Synapse formation in rodent models
- Cognitive recovery in animal models of Alzheimer's and Parkinson's
How it's used in practice
- There is no established human protocol of any kind
- Preclinical only — treat any human-use guidance as invented
What you should know before asking about it
- Research use only; not FDA-approved
- No human safety data
- Growth-factor pathway activation in the brain has unknown long-term consequences
Frequently asked questions.
- What is Dihexa?
- Dihexa is a small molecule derived from angiotensin IV, studied for potent effects on HGF/c-Met signaling and synaptogenesis in animal models of cognitive impairment. Its reported potency is exactly why caution is warranted.
- What is Dihexa studied for?
- Published and ongoing research looks at synapse formation in rodent models; cognitive recovery in animal models of Alzheimer's and Parkinson's. These are areas of study, not promised outcomes.
- Is Dihexa FDA-approved?
- Dihexa has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is Dihexa typically used?
- There is no established human protocol of any kind Preclinical only — treat any human-use guidance as invented Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with Dihexa?
- Research use only; not FDA-approved No human safety data Growth-factor pathway activation in the brain has unknown long-term consequences
Sources
- 1.Published literature on Dihexa— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Sleep, cognition & neuro
DSIP
A neuropeptide studied for its effect on slow-wave sleep architecture and stress response.
Selank
A synthetic analog of the immunopeptide tuftsin studied for anxiolytic and stress-response effects.
Semax
An ACTH(4-10) analog studied for attention, memory and neuroprotection.